We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fujirebio Europe Launches RoboBlot Instrument for Fully Automated Processing of INNO-LIA Score Assays

By LabMedica International staff writers
Posted on 19 Jan 2022

Fujirebio Europe (Gent, Belgium) has announced today the commercial launch of the RoboBlot instrument, a closed system for the automated processing of the widely used INNO-LIA Score assays.

The system’s pre-programmed test protocols provide start-to-finish automation of strip-based INNO-LIA Score assays, from sample addition, over strip processing, image capture, to result interpretation and where applicable laboratory information system (LIS) communication.


Image: RoboBlot (Photo courtesy of Fujirebio)
Image: RoboBlot (Photo courtesy of Fujirebio)

RoboBlot extends the range of automated solutions already offered by Fujirebio Europe for the INNO-LIA Score assay portfolio. It offers high-throughput testing, full automation with pipetting up to 50 samples and integrated camera for scanning and interpretation with Fujirebio LiRAS software, providing complete traceability with minimal hands-on time. It offers a customized fit with individual laboratory needs. Other automated solution for this portfolio is the TENDIGO.

“High throughput testing and more automation are an increasingly pressing need for laboratories. The typical drawbacks of manual testing, such as long hands-on time, inconsistent assay handling and issues with traceability, will become part of the past,” said Christiaan De Wilde, CEO at Fujirebio Europe. “The RoboBlot instrument will radically improve the laboratory workflow for our customers, from tedious manual or semi-automated work into fully automated testing.”

Related Links:
Fujirebio Europe 


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
Specimen Radiography System
TrueView 200 Pro
New
ESR Analyzer
TEST1 2.0

Latest Molecular Diagnostics News

Routine Blood Draws Could Detect Epigenetic Biomarkers for Predicting Cardiovascular Disease Risk
19 Jan 2022  |   Molecular Diagnostics

Single Cell RNA Sequencing Could Enable Non-Invasive Blood Disorder Diagnosis
19 Jan 2022  |   Molecular Diagnostics

Blood Test Identifies HPV-Associated Head and Neck Cancers 10 Years Before Symptoms
19 Jan 2022  |   Molecular Diagnostics